Short Interest in Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) Rises By 7,281.8%

Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) saw a significant growth in short interest in June. As of June 30th, there was short interest totaling 812 shares, a growth of 7,281.8% from the June 15th total of 11 shares. Approximately 0.2% of the company’s stock are short sold. Based on an average daily volume of 3,083 shares, the short-interest ratio is currently 0.3 days.

Institutional Investors Weigh In On Innovator IBD Breakout Opportunities ETF

A number of institutional investors have recently bought and sold shares of BOUT. Osaic Holdings Inc. grew its stake in Innovator IBD Breakout Opportunities ETF by 39.7% during the 2nd quarter. Osaic Holdings Inc. now owns 2,102 shares of the company’s stock valued at $77,000 after acquiring an additional 597 shares in the last quarter. Susquehanna International Group LLP boosted its holdings in shares of Innovator IBD Breakout Opportunities ETF by 42.6% during the third quarter. Susquehanna International Group LLP now owns 26,176 shares of the company’s stock worth $1,020,000 after purchasing an additional 7,817 shares during the period. Finally, Comprehensive Wealth Management LLC boosted its holdings in shares of Innovator IBD Breakout Opportunities ETF by 122.0% during the fourth quarter. Comprehensive Wealth Management LLC now owns 23,403 shares of the company’s stock worth $850,000 after purchasing an additional 12,859 shares during the period.

Innovator IBD Breakout Opportunities ETF Stock Down 0.7%

Shares of Innovator IBD Breakout Opportunities ETF stock traded down $0.35 during midday trading on Friday, hitting $46.66. The company’s stock had a trading volume of 1,926 shares, compared to its average volume of 4,263. Innovator IBD Breakout Opportunities ETF has a 1-year low of $35.05 and a 1-year high of $49.41. The firm has a market capitalization of $16.33 million, a P/E ratio of 28.69 and a beta of 1.03. The stock has a 50-day simple moving average of $46.89 and a 200-day simple moving average of $42.29.

About Innovator IBD Breakout Opportunities ETF

The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is managed by Innovator.